Related references
Note: Only part of the references are listed.AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
Mihaly Varadi et al.
NUCLEIC ACIDS RESEARCH (2022)
Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation
Caleb R. Glassman et al.
SCIENCE (2022)
Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors
Lu Cui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
MPL mutations in essential thrombocythemia uncover a common path of activation with eltrombopag dependent on W491
Gabriel Levy et al.
BLOOD (2020)
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations
Stephan Wilmes et al.
SCIENCE (2020)
A Conserved Proline Hinge Mediates Helix Dynamics and Activation of Rhodopsin
Andreyah L. Pope et al.
STRUCTURE (2020)
Differential effect of inhibitory strategies of the V617 mutant of JAK2 on cytokine receptor signaling
Emilie Leroy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and -secretase processing of the C99 peptide
Tzu-Chun Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation
Ryan D. Ferrao et al.
ELIFE (2018)
The Colony-Stimulating Factor 3 Receptor T64ON Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I
Julia E. Maxson et al.
CLINICAL CANCER RESEARCH (2016)
His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor
Emilie Leroy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms
J-P Defour et al.
LEUKEMIA (2016)
Crystal Structure of a Complex of the Intracellular Domain of Interferon λ Receptor 1 (IFNLR1) and the FERM/SH2 Domains of Human JAK1
Di Zhang et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Transmembrane Helices Tilt, Bend, Slide, Torque, and Unwind between Functional States of Rhodopsin
Zhong Ren et al.
SCIENTIFIC REPORTS (2016)
Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
Ignacio Moraga et al.
CELL (2015)
Structural basis of recognition of interferon-α receptor by tyrosine kinase 2
Heidi J. A. Wallweber et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
A lipid-mediated conformational switch modulates the thermosensing activity of DesK
Maria Eugenia Inda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
Andrew J. Brooks et al.
SCIENCE (2014)
Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides
Chihiro Matsushita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation
Jean-Philippe Defour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F
Rajintha M. Bandaranayake et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
MPL Mutation Profile in JAK2 Mutation-negative Patients With Myeloproliferative Disorders
Wanlong Ma et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2011)
Orientation-specific signalling by thrombopoietin receptor dimers
Judith Staerk et al.
EMBO JOURNAL (2011)
Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation
Erin E. Matthews et al.
FASEB JOURNAL (2011)
The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
Daniela Ungureanu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Transmembrane Helix Dynamics of Bacterial Chemoreceptors Supports a Piston Model of Signalling
Benjamin A. Hall et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor
Christian Pecquet et al.
BLOOD (2010)
The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity
Jianmin Ding et al.
BLOOD (2009)
Packing Density of the Erythropoietin Receptor Transmembrane Domain Correlates with Amplification of Biological Responses
Verena Becker et al.
BIOCHEMISTRY (2008)
MPL mutations in myeloproliferative disorders:: analysis of the PT-1 cohort
Philip A. Beer et al.
BLOOD (2008)
Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche
Hiroki Yoshihara et al.
CELL STEM CELL (2007)
Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells
Hong Qian et al.
CELL STEM CELL (2007)
Cytokine receptors and hematopoietic differentiation
L. Robb
ONCOGENE (2007)
Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation
Ning Yang et al.
MOLECULAR ENDOCRINOLOGY (2007)
A highly sensitive protein-protein interaction assay based on Gaussia luciferase
Ingrid Remy et al.
NATURE METHODS (2006)
MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients
Animesh D. Pardanani et al.
BLOOD (2006)
gp130 dimerization in the absence of ligand: Preformed cytokine receptor complexes
Stephanie Tenhumberg et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Ligand-independent homo- and heterodimerization of human prolactin receptor variants: Inhibitory action of the short forms by heterodimerization
Aamer M. Qazi et al.
MOLECULAR ENDOCRINOLOGY (2006)
NMR spectroscopy of basic/aromatic amino acid clusters in membrane proteins
Wenyi Zhang et al.
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor
J Staerk et al.
BLOOD (2006)
Janus kinases affect thrombopoietin receptor cell surface localization and stability
Y Royer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family
S McLaughlin et al.
JOURNAL OF GENERAL PHYSIOLOGY (2005)
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
F Ding et al.
BLOOD (2004)
The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor
LJS Huang et al.
MOLECULAR CELL (2001)
Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain
SN Constantinescu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif
SN Constantinescu et al.
MOLECULAR CELL (2001)
Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase
CA Bell et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Generation of mammalian cells stably expressing multiple genes at predetermined levels
XD Liu et al.
ANALYTICAL BIOCHEMISTRY (2000)
Regulation of the Jak2 tyrosine kinase by its pseudokinase domain
P Saharinen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)